Integrating in vivo and ex vivo approaches for culprit drug identification in cutaneous adverse drug reactions from non-beta lactam antibiotics

Exp Dermatol. 2024 Apr;33(4):e15074. doi: 10.1111/exd.15074.

Authors

Narumol Ratanasutiranont¹, Pungjai Mongkolpathumrat^{2

3}, Patcharapong Rujirawan¹, Pawinee Rerknimitr¹, Jettanong Klaewsongkram²

Affiliations

¹ Division of Dermatology, Department of Medicine, Faculty of Medicine, Center of Excellence for Skin and Allergy Research, Chulalongkorn University, Bangkok, Thailand.
² Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Medicine, Center of Excellence for Skin and Allergy Research, Chulalongkorn University, Bangkok, Thailand.
³ King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

PMID: 38651364
DOI: 10.1111/exd.15074

No abstract available

Keywords: ELISpot; cutaneous adverse reaction; intradermal test; non‐beta lactam antibiotics; oral provocation test.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents* / adverse effects
Drug Eruptions / etiology
Humans
Skin

Substances

Anti-Bacterial Agents

Grants and funding

RCU_H_64_021_30/The Ratchadapiseksomphot Endowment Fund, Chulalongkorn University